Arbatin Tablet 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Medix Pharmaceutical Co., Ltd.
MFDS item code 201900171 · Approved 2019.01.14
This product's status changed to Expired on 2024.01.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Reduction of risk of myocardial infarction and stroke, improvement of hypercholesterolemia
This medication is used to reduce the risk of cardiovascular disease. It decreases the risk of myocardial infarction, stroke, need for vascular interventions, angina, and hospitalization for congestive heart failure in adults with multiple risk factors for coronary heart disease and in patients with type 2 diabetes. It also effectively helps improve cholesterol and lipid levels in patients with primary hypercholesterolemia or mixed dyslipidemia, dysbeta-lipoproteinemia, and hypertriglyceridemia. It can be safely used in pediatric patients aged 10 to under 17 years with hypercholesterolemia persisting despite dietary measures. This medication is used to manage risk factors for cardiovascular disease and improve cholesterol levels to enhance overall heart health.
For the treatment of hyperlipidemia, the recommended initial dose is 10 mg once daily; for patients needing greater reductions in LDL cholesterol, treatment may begin at 20 mg or 40 mg once daily. The dose should be adjusted within the range of 10 to 80 mg once daily, individualized based on treatment goals and patient response. Lipid levels should be analyzed within 2 to 4 weeks after treatment initiation to adjust the dose. The treatment goal is to lower LDL cholesterol levels, so LDL cholesterol should be monitored during treatment initiation and evaluation. If LDL cholesterol levels are not available, total cholesterol levels can be used to monitor therapeutic response.
For pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17), the recommended initial dose is 10 mg once daily, with a maximum dose of 20 mg once daily. Dose adjustment should be made according to treatment goals.
This medication may cause unusual muscle symptoms, and if severe muscle pain or weakness occurs or creatine kinase levels rise significantly, it should be discontinued immediately. Patients with impaired liver function or active liver disease should not use this medication. Patients with muscle disorders or suspected muscle disorders, pregnant or potentially pregnant women, children under 10 years of age, and patients taking certain medications should also avoid using this medication. Patients with a history of alcohol dependence or liver disease should use this medication cautiously, and those at risk for muscle issues should have their muscle enzyme levels checked before treatment. This medication is generally safe, but side effects such as muscle pain, dyspepsia, headache, allergic reactions, and liver function abnormalities may occasionally occur, so consultation with a physician is advisable if symptoms worsen. Taking this medication in conjunction with certain antibiotics, antifungals, and antiviral agents may increase blood concentration and risk of side effects; therefore, inform your physician of any concomitant medications. Women who are pregnant or breastfeeding should not take this medication, and women of childbearing age should use appropriate contraception while on treatment. Elderly patients or those with reduced kidney function are at higher risk for muscle-related side effects, so careful administration under physician guidance is necessary. In case of overdose, there is no specific antidote, so symptomatic treatment should be given, and liver function and muscle enzymes should be monitored regularly. Keep this medication out of reach of children, store it in its original container, and do not transfer it to other containers.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash accompanied by high fever, blisters, skin peeling, pain in mouth/eye mucosa, severe skin reactions, shortness of breath or difficulty breathing, asthma attack, respiratory issues with cough + fever, jaundice (yellowing of skin or eyes), extreme lethargy, liver abnormalities (jaundice), sudden and severe headache, thunderclap headache, fainting
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture; therefore, it should be stored in a tightly closed container. Additionally, avoid extremely hot or cold places, and it is recommended to store it at room temperature between 1 and 30 degrees Celsius.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Medix Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.